Two major clinical trials are testing for the first time whether treating inflammation can reduce the risk of a heart attack or stroke, potentially opening up a new line of attack in the battle against cardiovascular disease. Both trials are led by Paul M. Ridker, Eugene Braunwald Professor of Medicine at HMS and director of the center for cardiovascular-disease prevention at Brigham and Women’s Hospital.
